IMMUNOTHERAPY OF HEPATOCELLULAR-CARCINOMA WITH AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND OR RECOMBINANT INTERLEUKIN-2

被引:32
作者
ISHIKAWA, T
IMAWARI, M
MORIYAMA, T
OHNISHI, S
MATSUHASHI, N
SUZUKI, G
TAKAKU, F
机构
[1] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN
[2] NATL INST RADIOL SCI,DIV RADIAT HLTH,CHIBA 260,JAPAN
关键词
D O I
10.1007/BF00405835
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:283 / 290
页数:8
相关论文
共 21 条
[11]  
LOTZE MT, 1985, J IMMUNOL, V135, P2865
[12]  
MAZUMDER A, 1984, CANCER-AM CANCER SOC, V53, P896, DOI 10.1002/1097-0142(19840215)53:4<896::AID-CNCR2820530414>3.0.CO
[13]  
2-E
[14]  
MULE JJ, 1985, J IMMUNOL, V135, P646
[15]   ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED PULMONARY METASTASES WITH LAK CELLS AND RECOMBINANT INTERLEUKIN-2 [J].
MULE, JJ ;
SHU, SY ;
SCHWARZ, SL ;
ROSENBERG, SA .
SCIENCE, 1984, 225 (4669) :1487-1489
[16]  
RAYNER AA, 1985, CANCER, V55, P1327, DOI 10.1002/1097-0142(19850315)55:6<1327::AID-CNCR2820550628>3.0.CO
[17]  
2-O
[18]  
ROSENBERG SA, 1984, J BIOL RESP MODIF, V3, P501
[19]  
ROSENBERG SA, 1984, CANCER TREAT REP, V68, P233
[20]   OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
LEITMAN, S ;
CHANG, AE ;
ETTINGHAUSEN, SE ;
MATORY, YL ;
SKIBBER, JM ;
SHILONI, E ;
VETTO, JT ;
SEIPP, CA ;
SIMPSON, C ;
REICHERT, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23) :1485-1492